TABLE 1 Primary (Stage IE)Non-Hodgkin’s Lymphoma of the Ovary

From: Ovarian Non-Hodgkin’s Lymphoma: A Clinicopathologic Study of Eight Primary Cases

Case No.

Age (y)

Presentation

Side

Size (cm)

Diagnosis

Immunophenotype

Therapy

Follow-Up

      

Lineage

CD10

CD99

Bcl-2

Bcl-6

  

1

29

Pelvic pain

R

13

T-LBL

T-cell

+

+

ND

TAH-BSO, CT

NED, 5.8 y

2

39

Incidental finding

R

Microscopic

ALCL

T-cell

ND

ND

ND

ND

TAH-BSO

NED, 4 y

3

41

Urinary frequency, incontinence

L

18

DLBCL

B-cell

+

+

BSO, CT, RT

NED, 5.5 y

4

43

Pelvic pain

R

8

DLBCL

B-cell

+

+

+

TAH-BSO, CT

NED, 6 y

5

50

Incidental finding

R

Microscopic

Follicular lymphoma, Grade 2

B-cell

+

+

TAH-BSO, CT

NED, 3.5 y

6

51

Incidental finding

R

Microscopic

Follicular lymphoma, Grade 3

B-cell

+

+

TAH-BSO, CT

NED, 1.3 y

7

59

Pelvic mass

R

7.5

DLBCL with follicular areas

B-cell

+

+

BSO, CT

NED, 3.5 y

8

62

Constitutional symptoms, NOS

R

20

Burkitt Lymphoma

B-cell

ND

+

CT, RT

NED, 11.7 y

  1. ALCL, anaplastic large cell lymphoma; BSO, bilateral salpingo-oophorectomy; CT, chemotherapy; DLBCL, diffuse large B-cell lymphoma; ER, estrogen receptor; ND, not done; NED, no evidence of disease; NOS, not otherwise specified (detailed clinical information of presentation not available); PR, progesterone receptor; RT, radiotherapy; TAH, total abdominal hysterectomy; T-LBL, precursor T-lymphoblastic lymphoma; +, positive; −, negative.